In 2024, the number of outpatient visits at KN Hospital (02120) is about 558,200, an increase of 11.5% compared to the previous year.
Kangning Hospital (02120) announced that in the 2024 fiscal year, the total average daily inpatient expenses were 361 yuan per bed, a year-on-year...
KN HOSPITAL (02120) announced that in the annual year of 2024, the average total cost per bed day for inpatient care was 361 yuan, a decrease of 5.0% compared to the previous year; the number of outpatient visits was approximately 558,200, an increase of 11.5% compared to the previous year; and the average total cost per outpatient visit was 374 yuan, a decrease of 14.2% compared to the previous year.
In the fourth quarter of 2024, the average total cost per bed day for inpatient care was 344 yuan, a decrease of 3.6% compared to the previous year; the number of outpatient visits was approximately 188,900, an increase of 55% compared to the previous year; and the average total cost per outpatient visit was 256 yuan, a decrease of 45.1% compared to the previous year.
Related Articles

BQD (03866) registered a net profit attributable to shareholders of 3.992 billion yuan in the first three quarters, an increase of 15.54% year-on-year.

J&T EXPRESS-W (01519) purchased 385,000 shares for HK$3.8812 million on October 28th.

In the first three quarters, the net profit attributable to the mother of Tractor (00038) was 994 million yuan, a year-on-year decrease of 9.69%.
BQD (03866) registered a net profit attributable to shareholders of 3.992 billion yuan in the first three quarters, an increase of 15.54% year-on-year.

J&T EXPRESS-W (01519) purchased 385,000 shares for HK$3.8812 million on October 28th.

In the first three quarters, the net profit attributable to the mother of Tractor (00038) was 994 million yuan, a year-on-year decrease of 9.69%.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


